The convergence moment is now.
PonieTech Industries is raising a $1M pre-seed SAFE round to advance Project Juvet through Phase 1 and Phase 2 development. We are engaging investors who recognize the significance of this convergence and the opportunity to help shape what comes next.
Four segments. One unsolved problem.
Across every domain that relies on teleoperated robotics, a core limitation remains: the operator cannot truly feel what the robot touches. This is the embodiment gap. PonieTech is developing a biologically informed approach to addressing this challenge, moving beyond traditional mechanical feedback systems. The $70B+ total addressable market spans four major segments with clear, economically significant need. Initial focus is surgical robotics, offering a defined regulatory pathway and established reimbursement infrastructure.
Loss of haptic feedback in robotic surgery. Over 1.5M da Vinci procedures performed annually with no tactile feedback available to the operating surgeon.
Nuclear, chemical, offshore, and EOD operators working blind through robotic proxies in environments where human presence means unacceptable risk.
QKD-secured command channels physically impossible to intercept or jam. Security is a property of physics, not software.
40 percent prosthetic abandonment rate driven primarily by the absence of tactile feedback. A pathway to restoring genuine sensory experience.
Two rounds. Fully mapped to milestones.
Pre-Seed Round
- Phase 1: Bioprinting foundation and construct fabrication
- Phase 2: Micro-ILED integration and ChR2 transduction
- Personnel: Founding team through Year 2
- Infrastructure: Lab infrastructure and CRO partnerships
- IP: Provisional filed USPTO March 29, 2026
- Regulatory: Strategy development and pre-IND planning
Series A
- Phase 3: Entanglement layer and QKD integration
- Phase 4: Full system integration and first prototype
- Regulatory: FDA pre-submission meeting and pathway development
- IP: Non-provisional prosecution, 5 families
- Team: R&D, regulatory, and commercial leads
- Deployment: First pilot and clinical evidence generation
Four layers. One biological construct.
Project Juvet integrates four independently peer-reviewed capabilities into a single co-fabricated bioprinted construct for the first time. Each layer rests on validated science from leading research institutions.
Quantum Ion-Pair Sensing
Entangled Ca²⁺ ion-pair mesh reads neural pre-motor signals at sensitivity beyond the classical noise floor.
QKD Photon Channel
Quantum key distribution physically impossible to intercept or jam. Security is a property of physics, not software.
Photonic AI Inference
Sub-milliwatt photonic inference chip powered by body heat. No cloud. No battery. No delay.
Optogenetic Haptics
ChR2-expressing cells deliver biological haptic sensation. The operator does not feel a simulation of touch. The operator feels.
Five patent families. Five competitive moats.
Looking Glass Robotics has filed a provisional patent application with the USPTO establishing a priority date of March 29, 2026. The application covers the complete Project Juvet integrated system architecture. Non-provisional prosecution begins within 12 months.
The IP strategy encompasses Madrid Protocol international filing in EU, Japan, South Korea, China, and Israel concurrent with US non-provisional filing, and trademark registration for PonieTech Industries, Looking Glass Robotics, and Project Juvet.
The right conversation starts here.
Request the full investor deck, operating budget model, technical research paper, and bill of materials. All materials provided under NDA to qualified investors.
All investor materials provided under NDA. We respond to every serious inquiry within 24 hours.